SANUWAVE Health (SNWV) 10-Q2020 Q2 Quarterly report

Filed: 14 Aug 20, 5:16pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: acquire, acquired, automatically, belief, Biovance, buy, Celularity, combat, compensatory, concurring, connection, Consultoria, COVID, customary, declined, delayed, deployed, discretion, doctor, EIDL, EIRELI, em, entirety, essential, evidenced, exact, exclusive, extinguishment, faith, feature, Field, forecast, forgiven, greatly, headcount, IDIC, inducement, ineligible, Interfyl, iv, legend, lender, LGH, light, loan, LP, Ltda, Meeting, million, NH, noteholder, NWPSA, owed, owing, Paycheck, PPP, prepayment, program, Protection, ratio, Release, Small, split, support, Territory, thereof, thereon, thousand, Truist, UltraMIST, unreserved, Versani, Wainwright, widely, written

Removed: accreted, adjusted, borrower, collection, collectively, customer, defendant, Delaware, derivative, embedded, end, identify, incentive, issuable, modified, principle, recognize, reflect, refurbished, retrospective, shipped, subsidiary, warranty, wholly

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

SNWV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION

In connection with the periodic report of SANUWAVE Health, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2020 as filed with the Securities and Exchange Commission (the “Report”), I, Kevin A. Richardson II, Chief Executive Officer (and principal executive officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Date: August 14, 2020

/s/ Kevin A. Richardson II

Kevin A. Richardson II

Chief Executive Officer

(principal executive officer)